Dr. Dinesh S. Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Dinesh S. Patel, a Promoter of Gujarat Themis Biosyn Limited, has submitted a disclosure confirming that neither he nor the persons acting in concert (PAC) listed have created any new share encumbrances during the financial year ended 31st March, 2026. The filing also notes that prior pledges made by Pharmaceutical Business Group (India) Limited during FY 2023-24, and pledges by Themis Medicare Limited during FY 2025-26, had already been separately disclosed to BSE and NSE as required. The promoter/promoter group includes 8 entities: Dr. Dinesh S. Patel, Jayshree Dinesh Patel, Sachin Dinesh Patel, Reena Sachin Patel, Anand Rupen Choksi, Nysha Rupen Choksi, Pharmaceutical Business Group (India) Ltd, and Themis Medicare Limited. This is a routine negative disclosure — no new encumbrances were created in the reporting period.
This filing is a compliance disclosure indicating no fresh pledge activity by promoters during FY 2025-26, which is neutral to positive for shareholders as it signals no increase in promoter-level debt or risk of pledge invocation on the company's shares.